NASDAQ:BCTX

Briacell Therapeutics Stock Insider Trading

etoro logo Buy BCTX
*Your capital is at risk
$3.44
-0.190 (-5.23%)
At Close: Jul 31, 2026

BriaCell Therapeutics Stock Insider Power

Based on the 60 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 6.18M and sold 0 BCTX shares in the last 60 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 60 transactions)
0
Buy 6.18M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Mar 29, 2021
Buy
Option (Right to Buy)
Williams Williams V.
President & CEO
CEO / President 200 000
Value: $848.0K
Mar 29, 2021
Buy
Option (Right to Buy)
Levin Gadi
CFO & Secretary
C-Suite Officer 75 000
Value: $318.0K
Mar 29, 2021
Buy
Option (Right to Buy)
Schmieg Martin E.
Director
Director 25 000
Value: $106.0K
Mar 29, 2021
Buy
Option (Right to Buy)
Taub Rebecca
Director
Director 10 000
Value: $42.4K
Mar 29, 2021
Buy
Option (Right to Buy)
Embro-pantalony Vaughn C.
Director
Director 25 000
Value: $106.0K
Mar 29, 2021
Buy
Option (Right to Buy)
Taub Rebecca
Director
Director 10 000
Value: $42.4K
Mar 29, 2021
Buy
Option (Right to Buy)
Schmieg Martin E.
Director
Director 25 000
Value: $106.0K
Mar 29, 2021
Buy
Option (Right to Buy)
Embro-pantalony Vaughn C.
Director
Director 25 000
Value: $106.0K
Mar 29, 2021
Buy
Option (Right to Buy)
Williams Williams V.
President & CEO
CEO / President 200 000
Value: $848.0K
Mar 29, 2021
Buy
Option (Right to Buy)
Levin Gadi
CFO & Secretary
C-Suite Officer 75 000
Value: $318.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT BRIACELL THERAPEUTICS CORP.
BriaCell Therapeutics
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immun...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE